Serrapeptase: An Overview

1) Conditions Studied

Serrapeptase, a proteolytic enzyme, has been studied for various conditions, including chronic inflammation, pain management, cardiovascular health, and the reduction of mucus in the respiratory system. It has been researched in the context of post-surgical healing, sinusitis, carpal tunnel syndrome, and even fibrocystic breast disease.

2) Efficacy in Treating Conditions

The effectiveness of serrapeptase in treating these conditions remains a subject of ongoing research. Some studies suggest that it may help reduce inflammation and pain, but the evidence is not conclusive. While many users report positive outcomes, the scientific community calls for more rigorous clinical trials to establish its efficacy and safety profile fully.

3) Health Benefits

Serrapeptase is purported to offer several health benefits, such as reducing inflammation, thinning mucus, and supporting the body's healing processes. Its anti-inflammatory properties are thought to be beneficial in managing conditions like sinusitis and joint pain, and its ability to break down non-living tissue may aid in postoperative recovery and fibrocystic breast disease.

4) Downsides

While serrapeptase is generally regarded as safe for short-term use, potential downsides include allergic reactions, gastrointestinal disturbances, and possible interactions with other medications, particularly blood thinners. Long-term safety data is limited, and individuals should consult with healthcare professionals before incorporating serrapeptase into their regimen.

5) Genetic Variations

There is currently limited research on the interaction between serrapeptase and specific genetic variations. Some individuals may have genetic predispositions that affect enzyme function or the inflammatory response, which could theoretically alter the effectiveness or safety profile of serrapeptase. However, concrete evidence to support specific recommendations based on genetic makeup is lacking at this time.

Research Summary on Serrapeptase

Effectiveness in Orthopedic Implant Infections

Serratiopeptidase combined with antibiotics significantly reduced infection rates in a rat model with orthopedic implant infections caused by Staphylococcus epidermidis compared to antibiotics alone.

Systematic Review on Efficacy and Safety

A systematic review found that most clinical studies on Serratiopeptidase have poor methodology, and there is insufficient evidence supporting its use for anti-inflammatory, anti-edemic, and analgesic effects, highlighting the need for more rigorous research.

Challenges in Oral Delivery

Understanding the types and quantities of gastrointestinal enzymes is crucial for developing effective delivery strategies for therapeutic peptides and proteins, as these substances face degradation in the digestive tract.

Enhancing Antibiotic Concentration in Oral Tissues

Research indicates that serratiopeptidase can significantly increase the concentration of various antibiotics in the gingiva, improving their efficacy in areas affected by infection.

Postoperative Swelling and Pain Reduction

A study showed that serrapeptase reduced postoperative swelling by 50% on the third day after ankle surgery, indicating faster pain relief than conventional treatments.

Improving Drug Absorption Predictions

The Theoretical Passive Absorption Model (TPAM) has been shown to accurately predict oral drug absorption and could be a useful tool in drug development.

Reducing Dental Surgery Complications

Serrapeptase significantly reduced cheek swelling and pain intensity after the surgical removal of wisdom teeth, but did not significantly affect mouth opening.

Impact on Nasal Mucus Flow and Elasticity

Serratiopeptidase was observed to lower the viscosity of nasal mucus in adults with chronic sinusitis without affecting its elasticity.

Enzyme Production Induction by Glycerol

The addition of glycerol to a gelatin medium increased bacterial growth but reduced the specific activity of proteases produced by Serratia marcescens.

Reducing Buccal Swelling Post-Surgery

Serrapeptase effectively and safely reduced buccal swelling following Caldwell-Luc antrotomy for chronic empyema.

Optimizing Serratiopeptidase Production

Optimal fermentation conditions for producing serratiopeptidase from Serratia marcescens were identified, resulting in increased enzyme production.

Distribution of Antibiotics in Lung Tissues

Serratiopeptidase affected the distribution of the antibiotic cefotiam in rabbit lung tissues, especially those with pneumonitis and pleuritis, potentially enhancing antibiotic concentrations.

Comparing Drug Efficacy Post-Dental Surgery

Betamethasone and ibuprofen were more effective than serratiopeptidase in reducing pain and swelling after dental surgery.

Analyzing Cellular Components of Nasal Secretions

Dithiothreitol (DTT) was the most effective among five mucus-liquefying agents in preparing quantitative cytological analyses of nasal secretions from chronic paranasal sinusitis patients.

Improving Mucus Clearance in Chronic Airway Diseases

Treatment with serrapeptase may enhance mucus clearance by altering its viscoelastic properties and reducing the number of neutrophils in the sputum.

Effects of Serratiopeptidase on Enzyme Production

Serratia marcescens produces extracellular proteases in media without protein or protein derivatives only under conditions that support robust bacterial growth and the formation of bacterial clusters.

Viscoelastic Properties of Sputum

Proteolytic enzymes significantly changed the frequency dependence of sputum viscoelasticity, suggesting they broke down the molecular structure of sputum in chronic pulmonary diseases.

References:

1. The effect of proteolytic enzyme serratiopeptidase in the treatment of experimental implant-related infection
2. Serratiopeptidase: a systematic review of the existing evidence
3. Enzymatic barriers for GI peptide and protein delivery
4. [Studies on the distributions of antibiotics in the oral tissues: Experimental staphylococcal infection in rats, and effect of serratiopeptidase on the distributions of antibiotics (author's transl)]
5. [Reduction of postoperative swelling. Objective measurement of swelling of the upper ankle joint in treatment with serrapeptase-- a prospective study]
6. Prediction of oral drug absorption in humans by theoretical passive absorption model
7. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars
8. Shapes of membrane permeability-lipophilicity curves: extension of theoretical models with an aqueous pore pathway
9. Effects of orally administered drugs on dynamic viscoelasticity of human nasal mucus
10. Regulation of extracellular protease formation by Serratia marcescens
11. A multi-centre, double-blind study of serrapeptase versus placebo in post-antrotomy buccal swelling
12. Biofilm dispersal: mechanisms, clinical implications, and potential therapeutic uses
13. Media optimization studies for Serratiopeptidase production from Serratia marcescens ATCC 13880
14. [Experimental studies on distribution of cefotiam, a new beta-lactam antibiotic, in the lung and trachea of rabbits. II. Combined effects with serratiopeptidase]
15. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model
16. A technique for quantitative cytology of nasal secretions
17. Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease
18. Effects of dissolved oxygen and agitation on production of serratiopeptidase by Serratia marcescens NRRL B-23112 in stirred tank bioreactor and its kinetic modeling
19. Comparison of anti-inflammatory activity of serratiopeptidase and diclofenac in albino rats
20. Liposomal formulations of serratiopeptidase: in vitro studies using PAMPA and Caco-2 models
21. Proteolytic enzymes: a new treatment strategy for prosthetic infections?
22. Topical formulations of serratiopeptidase: development and pharmacodynamic evaluation
23. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme
24. Bacterial biofilms in nature and disease
25. The treatment of breast engorgement with Serrapeptase (Danzen): a randomised double-blind controlled trial
26. Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme
27. Aquasomes: a promising carrier for peptides and protein delivery
28. Intestinal absorption of serrapeptase (TSP) in rats
29. Effect of some clinically used proteolytic enzymes on inflammation in rats
30. Studies on the biosynthesis of extracellular proteases by bacteria. I. Serratia marcescens, synthetic and gelatin media
31. Effect of expectorants on relaxation behavior of sputum viscoelasticity in vivo
32. A preliminary trial of serratiopeptidase in patients with carpal tunnel Syndrome
33. Purification and characterization of four proteases from a clinical isolate of Serratia marcescens kums 3958
34. The giant extracellular matrix-binding protein of Staphylococcus epidermidis mediates biofilm accumulation and attachment to fibronectin
35. [Clinical study of the efficacy of and tolerance to seaprose S in inflammatory venous disease. Controlled study versus serratio-peptidase]
36. The effect of an orally administered proteolytic enzyme on the elasticity and viscosity of nasal mucus
37. A case of serratiopeptidase-induced subepidermal bullous dermatosis
38. Repression of fibrinolysis in scalded rats by administration of Serratia protease
39. A new anti-infective strategy to reduce adhesion-mediated virulence in Staphylococcus aureus affecting surface proteins
40. Comparison of the action of different proteases on virulence properties related to the staphylococcal surface
41. Protease treatment affects both invasion ability and biofilm formation in Listeria monocytogenes
42. Comparison of the roles of serratiopeptidase and dexamethasone in the control of inflammation and trismus following impacted third molar surgery
43. A preliminary trial of serratiopeptidase in patients with carpal tunnel syndrome

Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!